Advertisement
BIO vs MOBI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Hold and MOBI is a Hold.
BIO | MOBI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 57 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 88 Overvalued | 26 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 64 | |
SMR RATING 1..100 | 87 | 97 | |
PRICE GROWTH RATING 1..100 | 42 | 79 | |
P/E GROWTH RATING 1..100 | 9 | 100 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MOBI's Valuation (26) in the Packaged Software industry is somewhat better than the same rating for BIO (88) in the Medical Specialties industry. This means that MOBI’s stock grew somewhat faster than BIO’s over the last 12 months.
MOBI's Profit vs Risk Rating (64) in the Packaged Software industry is somewhat better than the same rating for BIO (100) in the Medical Specialties industry. This means that MOBI’s stock grew somewhat faster than BIO’s over the last 12 months.
BIO's SMR Rating (87) in the Medical Specialties industry is in the same range as MOBI (97) in the Packaged Software industry. This means that BIO’s stock grew similarly to MOBI’s over the last 12 months.
BIO's Price Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for MOBI (79) in the Packaged Software industry. This means that BIO’s stock grew somewhat faster than MOBI’s over the last 12 months.
BIO's P/E Growth Rating (9) in the Medical Specialties industry is significantly better than the same rating for MOBI (100) in the Packaged Software industry. This means that BIO’s stock grew significantly faster than MOBI’s over the last 12 months.
| BIO | MOBI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 82% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 78% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 63% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 72% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 66% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 90% |
| Advances ODDS (%) | 12 days ago 66% | N/A |
| Declines ODDS (%) | 3 days ago 67% | N/A |
| BollingerBands ODDS (%) | 2 days ago 77% | N/A |
| Aroon ODDS (%) | 2 days ago 66% | 2 days ago 80% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BIO’s FA Score shows that 1 FA rating(s) are green while MOBI’s FA Score has 1 green FA rating(s).
- BIO’s FA Score: 1 green, 4 red.
- MOBI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BIO’s TA Score shows that 6 TA indicator(s) are bullish while MOBI’s TA Score has 2 bullish TA indicator(s).
- BIO’s TA Score: 6 bullish, 3 bearish.
- MOBI’s TA Score: 2 bullish, 3 bearish.
Price Growth
BIO (@Medical/Nursing Services) experienced а -3.11% price change this week, while MOBI (@Medical/Nursing Services) price change was +1.32% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.13%. For the same industry, the average monthly price growth was -5.92%, and the average quarterly price growth was -2.70%.
Reported Earning Dates
BIO is expected to report earnings on Oct 22, 2026.
MOBI is expected to report earnings on Dec 02, 2026.
Industries' Descriptions
@Medical/Nursing Services (-2.13% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
BIO and
Correlation & Price change
A.I.dvisor indicates that over the last year, BIO has been closely correlated with A. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then A could also see price increases.
MOBI and
Correlation & Price change
A.I.dvisor tells us that MOBI and IART have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MOBI and IART's prices will move in lockstep.
| Ticker / NAME | Correlation To MOBI | 1D Price Change % | ||
|---|---|---|---|---|
| MOBI | 100% | +1.66% | ||
| IART - MOBI | 7% Poorly correlated | -21.19% | ||
| LAB - MOBI | 3% Poorly correlated | +2.25% | ||
| BRKR - MOBI | 1% Poorly correlated | +2.10% | ||
| IRIX - MOBI | 1% Poorly correlated | +1.58% | ||
| BIO - MOBI | -3% Poorly correlated | +3.82% | ||
More | ||||